Skip to main content

Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDS)

  • Recruiting

The purpose of this study is to learn about thinking and behavior in families in which one or more relatives has a genetic mutation associated with frontotemporal dementia.

Minimum Age Maximum Age Gender Healthy Volunteers
18 Years 90 Years Both Yes
April 2015
April 2019
300
  • Member of family with a known mutation in one of the three major genes related to frontotemporal dementia: MAPT, PGRN, or C9ORF72
  • Predominant type of dementia is cognitive/behavioral
  • Reliable family member, friend, or caregiver who speaks with or sees the participant at least weekly
  • Fluent in English
  • Willing and able to undergo neuropsychological testing (at least at baseline visit)
  • Contraindication to magnetic resonance brain imaging
  • Known presence of a structural brain lesion, such as a tumor or cortical infarct
  • Presence of another neurological disorder that could impact the study results

This observational study will enroll people from families affected by familial frontotemporal dementia. At least one relative must have a known mutation in the MAPT, PGRN, or C9ORF72 genes. The study will include 100 mutation carriers with mild dementia or minimal symptoms but no dementia, 100 mutation carriers without symptoms, and 100 clinically normal noncarriers.

Participants will undergo assessments, including different kinds of magnetic resonance imaging;  magnetic resonance spectroscopy; cerebrospinal fluid and blood sampling; and behavioral, neuropsychological, and functional tests. Investigators will measure changes in cognition during 3 years shown by these test results.

A primary goal of this study is to identify the most robust and reliable methods to track disease progression in familial frontotemporal dementia so that clinical trials of disease-modifying therapies can be designed appropriately.

Name City State Zip Status Primary Contact
University of California, San Francisco, Memory and Aging Center, Department of Neurology San Francisco California 94358 Recruiting Reilly Dever
415-476-0670
reilly.dever@ucsf.edu
Mayo Clinic Florida Jacksonville Florida 32224 Recruiting Dana Haley
904-953-9680
Haley.Dana@mayo.edu
Harvard University Charlestown Massachusetts 02129 Recruiting Samantha Krivensky
617-726-6205
skrivensky@mgh.harvard.edu
Mayo Clinic Rochester Minnesota 55905 Recruiting Christina Dheel
507-293-5551
dheel.christina@mayo.edu
Washington University Saint Louis Missouri 63110 Recruiting Lynne Jones
314-362-8420
jonesly@wustl.edu
Columbia University New York New York 10032 Recruiting Masood Manoochehri

mm2626@cumc.columbia.edu
Univerisity of Pennsylvania Phildelphia Pennsylvania 19104 Recruiting Christina Ray
215-349-5873
rayc@mail.med.upenn.edu
University of British Columbia Vancouver British Columbia V6T 2B5 Recruiting Pheth Sengdy
604 822 7989
Pheth.Sengdy@vch.ca

Mayo Clinic

  • National Institute on Aging (NIA) - NIH
  • National Institute of Neurological Disorders and Stroke (NINDS) - NIH

Name Role Affiliation
Bradley Boeve, MD Principal Investigator Mayo Clinic
Howard Rosen, MD Principal Investigator University of California, San Francisco

Name Phone Extension Email
Christina Dheel 507-293-5551 dheel.christina@mayo.edu
Josie Williams 507-293-5354 williams.josie@mayo.edu

Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects